A recent study has provided evidence that local complement activation of C3a and C5a in the TME results in an immunosuppressive response to melanoma through the recruitment of MDSCs and inhibition of CD8+ tumor infiltrating lymphocyte function [35]. The gene discussed is C3; the disease is neoplasm.